Zhu Ge, Yang Yong-Guang, Sun Tianmeng
Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
Biomater Sci. 2022 Mar 15;10(6):1408-1422. doi: 10.1039/d2bm00011c.
With rapid developments in medical science and technology, vaccination has become the key to solving public health problems. Various diseases can be prevented by vaccination, which mimic a disease by using a small part of the causal organism-also called an antigen-to stimulate the specific immune response to defend the host against the disease. The interaction between antigens and antigen-presenting cells (APCs) affects the efficacy of a vaccine. Adjuvants are crucial components of vaccines, optimizing the process of antigen phagocytosis by the APCs to some extent. However, many vaccinations fail during application in clinical trials owing to drawbacks of some antigens and adjuvants, such as immunogenicity and high degradability. Owing to rapid developments in the payload, targeted delivery and controllable release of drug delivery systems, they may have the potential to improve vaccines. In our review, we discuss multiple delivery systems and their role in vaccines and discuss how the major physical properties of delivery systems ultimately affect the success of vaccines, such as size, morphology, surface charge and elasticity.
随着医学科学技术的飞速发展,疫苗接种已成为解决公共卫生问题的关键。通过接种疫苗可以预防各种疾病,疫苗通过使用致病生物体的一小部分(也称为抗原)来模拟疾病,从而刺激特异性免疫反应,以保护宿主抵御疾病。抗原与抗原呈递细胞(APC)之间的相互作用会影响疫苗的效力。佐剂是疫苗的关键成分,在一定程度上优化了APC对抗原的吞噬过程。然而,由于一些抗原和佐剂存在免疫原性和高降解性等缺点,许多疫苗在临床试验应用中失败。由于药物递送系统在载药量、靶向递送和可控释放方面的快速发展,它们可能具有改进疫苗的潜力。在我们的综述中,我们讨论了多种递送系统及其在疫苗中的作用,并讨论了递送系统的主要物理性质(如尺寸、形态、表面电荷和弹性)最终如何影响疫苗的成功。
J Pharm Sci. 1996-12
Int J Pharm. 2019-10-24
RNA Biol. 2024-1
Eur J Med Chem. 2022-1-5
Immunol Cell Biol. 2004-12
Expert Opin Drug Deliv. 2023-3
Artif Cells Nanomed Biotechnol. 2018-10-11
Exploration (Beijing). 2024-7-17
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023